Publications 2004

  1. Principles of good modelling practice in healthcare cost-effectiveness studies. Expert Rev. Pharmacoeconomics Outcomes Res., 2004;4(2):189-198. Goeree R., O’Brien BJ., Blackhouse G.
  2. Antiviral agents for influenza: a comparison of cost-effectiveness data. Pharmacoeconomics (In Press 2004). Lynd LD, Goeree R, O’Brien BJ.
  3. AFFIRM and CORE investigators. Cost-Effectiveness of Rhythm Versus Rate Control for Treatment of Atrial Fibrillation: Results from the AFFIRM Trial. Annals of Internal Medicine. In press, Sept, 2004. Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Wyse G, Greene L, Nichol G, O’Brien B,
  4. Resistance to Antibiotics: Administrative Response to the Challenge. Manage Care Interface. In press, Sept 2004. Marshall DA, McGeer A, Jaszewski B, Grootendorst P, Green K, Laframboise M, Lam LA, MacLeod SM, Low DE.
  5. Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004;44:386-390. Kleinman SH, Marshall D, AuBuchon J, Patton M.
  6. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocrine Disorders 2004,4:2. Sawka AM, Prebtani APH, Thabane L, Gafni A, Levine M, Young Jr. WF.
  7. Pharmacological Treatment of Dementia. Evidence Report/Technology Assessment No. 97 (Prepared by McMaster University Evidence-based Practice Center under Contract No. 290-02-0020). AHRQ Publication No. 04-E018-2. Rockville, MD: Agency for Healthcare Research and Quality. April 2004. Santaguida PS, Raina P, Booker L, Patterson C, Baldassarre F, Cowan D, Gauld M, Levine M, Unsal A.
  8. Patient perceptions can be misleading in the assessment of clinical response to salbutanol metered dose inhalers (MDI). J Generic Drugs, in press. Levine MAH, Gaebel K.
  9. International Trends in Managing Drug Plans: Lessons for Canada. Policy Options, in press. Willison DJ, Wiktorowicz M, Grootendorst P, O'Brien B, Levine M, Deber R, Hurley J.
  10. The 2004 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension: Part 1: Blood pressure measurement, diagnosis, and assessment of risk. The Canadian Journal of Cardiology. Zarnke KB, Hemmelgarn B, McAlister FA, Khan N, Campbell NRC, Levine M et al.
  11. The 2004 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension: Part 2 Therapy. The Canadian Journal of Cardiology. Khan NA, McAlister FA, Zarnke KB, Hemmelgarn B, Campbell NRC, Feldman RD, Lewanczuk R, Mahon J, Rabkin SW, Lebel M, Levine M
  12. An assessment of Institutional Relocation: Qualitative Perceptions and Resident Outcomes, Stride. Excellence in Seniors Care, in press. Dalby D, Brazil K, Krueger P, Soluk R, Koch R, Walker M.
  13. Family perceptions of end of life care in long term care facilities. Journal of Palliative Care, in press. Vohra J, Brazil K, Hanna S, Abelson J.
  14. Service preference among family caregivers of the terminally ill. Journal of Palliative Medicine, in press. Brazil K, Bedard M, Krueger P, Abernathy T, Lohfeld L, Willison K.
  15. A Strategy to identify critical appraisal criteria for primary mixed-method studies. Quality and Quantity: International Journal of Methodology, in press. Sale J. Brazil K.
  16. Towards improving the coordination of supportive cancer care services in the community. Health Policy, 2004 70(1) 125-131. Brazil K, Whelan T, O’Brien MA, Sussman J, Pyetter N, Bainbridge D.
  17. Quality end-of-life in long term care facilities: service providers perspective. Journal of Palliative Care, 2004 20 (2) 85-92. Brazil K, McAiney C, O’Brien-Carron M, Kelley ML, O’Krafka P, Sturdy-Smith C.
  18. Promising quality care at the end-of-life. Stride. Excellence in Seniors Care, 2004 6(2) 6-11. Howell D, Brazil K.
  19. Moving to evidence-based practise in long term care: The role of a best practise resource centre in two long term care settings. Journal of Gerontological Nursing, 2004, 30(3), 14-19. Brazil K. Royle J. Montemuro M. Blythe, J. Church A.
  20. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sanguinis 2004;86:28-40. Marshall D, Kleinman SH, Wong, JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC.
  21. Discrimination for Generalized Multivariate Modified Bessel Distribution (to appear International Journal of Statistical Science 2004). Thabane L, Drekic S.
  22. Determining the Level of Statisticians’ Participation in Canadian-based Research Ethics Committees (to appear IRB 2004). Thabane L, Childs A, Lafontaine A.
  23. Are there Differences between Men and Women Prescribed Bisphosphonate Therapy in Canadian Subspecialty Osteoporosis Practices? (to appear Journal of Rheumatology 2004). Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH.
  24. A Systematic Review and Meta-analysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-differentiated Thyroid Cancer (to appear Journal of Clinical Endocrinology and Metabolism 2004). Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Driedger AA, Gerstein HG.
  25. The Economic Implications of Three Biochemical Testing Strategies for Pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 2004;89:2859-2866. Sawka AM, Gafni A, Thabane L, Young Jr. WF.
  26. On the Generalized Matrix-variate Hyperbolis Distribution and Its Application to the Bayesian Analysis of the Normal Linear Model (to appear Statistics 2004). Thabane L, Haq MS.
  27. Data-mining applications in pharmaco-surveillance. British Journal of Clinical Pharmacology 2004;57(2):127-134. Wilson A, Thabane L, Holbrook A.
  28. Spatialization of web sites using a weighted frequency model of navigation data. Journal of the American Society of Information Science and Technology 2004;55(1):13-22. Reitsma R, Thabane L, McLeod M.
  29. A Randomized Controlled Trial of Doxycycline and Rifampicin for Patients with Alzheimer Disease. J Amer Geriatric Soc 2004;52(3):381-387. Loeb MB, Molloy DW, Smieja MJ, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A, Gnarpe J, O’Donnell M, Chernesky M.
  30. What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy? J Clin Densitometry 2003;6(4):315-322. Sawka AM, Adachi JD, Ioannidis G, Olszynski W, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Papaioannou A, Goldsmith CH.
  31. Placebos: Our Most Effective Therapy?Can J Clin Pharmacol 2004;11:e9. Holbrook AM, Goldsmith CH.
  32. Muscle Weakness and Falls in Older Adults: A Systematic Review and Meta-analysis. J Amer Geriatric Soc 2004;52:1121-1129. Moreland JD, Richardson JA, Goldsmith CH, Clase CM.
  33. The perception of care from the perspective of patients with diabetes. Family Medicine. In press. Nair, KM, Dolovich LR, Ciliska DK, Lee HN.
  34. Attitudes of Women who Are currently using or Recently stopped Estrogen replacement therapy with or without progestins: Results of the AWARE Survey. Journal of Obstetrics and Gynaecology of Canada. In press. Sawka AM, Huh A, Adachi JD, Papaioannou A, Dolovich L, Eva K, Thabane L, Gafni A, Cullimore A, Macdougall M, Steiner M.
  35. The Diabetes Continuity of Care Scale: the development and evaluation of a scale that measures continuity from the patient perspective. Health and social care in the community. In press. Dolovich L, Nair K, Ciliska D, Lee H, Birch S, Gafni A, Hunt D.
  36. The administrative burden of a Limited Use Drug Policy for community pharmacists. Journal of Managed Care Pharmacy, January 2004. In press. Dolovich L, Lau E, MacLeod S, Mallon R.
  37. Prescribing of potentially inappropriate medications to elderly people. Family Practice; 2004:244-247. Howard M, Dolovich L, Kaczorowski J, Sellors C, Sellors J.
  38. Manipulation and Mobilisation for Mechanical Neck Disorders. Cochrane Library 2004;Issue 1 (should appear 2004-01). (Also accepted for publication in Spine, 2004-02-25.) Gross AR, Hoving JL, Haines AT, Goldsmith CH, Kay T, Aker P, Bronfort G, for the Cervical Overview Group.
  39. Are There Differences Between Men and Women Prescribed Bisphosphonate Therapy in Canadian Subspecialty Osteoporosis Practices? J Rheumatol. Accepted for publication 2004-05-13. Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davidson KS, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH.
  40. Noninvasive Physical Treatments for Chronic/Recurrent Headache. Cochrane Review, to appear in Issue 3, 2004. Bronfort G, Nilsson N, Evans R, Haas M, Goldsmith CH, Assendelft WJJ, Bouter LM.
  41. The impracticability of obtaining informed consent in the Registry of the Canadian Stroke Network. NEJM 2004;350(14):1414-1421. Tu JV, Willison DJ, Silver FL, Fang J, Richards J, Laupacis A, Kapral M.
  42. Post-Romanow Pharmacare: Last-dollar first … First dollar lost? HealthcarePapers 2004;4(3):10-19. Morgan SG, Willison DJ.
  43. Patients’ consent preferences regarding the use of their personal health information for research purposes: A qualitative study. Journal of Health Services Research and Policy 2004;9(1):22-27. Nair K, Willison DJ, Holbrook AM, Keshavjee K.
  44. Placebos: Our most effective therapy? Can J Clin Pharmacol 2004;11:e9. Holbrook A, Goldsmith C.
  45. Application of data mining techniques in pharmacovigilance. British Journal of Clinical Pharmacology 2004;57(2):127-134. Wilson AM, Thabane L, Holbrook A.
  46. Appropriateness of NSAID and coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario - results from the CANOAR study. (in press, Am J Managed Care 2004) Sebaldt RJ, Petrie A, Goldsmith CH, Marentette M.
Toronto Web Design by LinxSmart
Graphic Design by Electra